Logo image
Pilot study of focused ultrasound for drug-resistant epilepsy
Journal article   Open access   Peer reviewed

Pilot study of focused ultrasound for drug-resistant epilepsy

Cheng-Chia Lee, Chien-Chen Chou, Fu-Jung Hsiao, Yi-Hsiu Chen, Chun-Fu Lin, Ching-Jen Chen, Syu-Jyun Peng, Hao-Li Liu and Hsiang-Yu Yu
Epilepsia, Vol.63(1)
2022

Abstract

Animals Drug Resistant Epilepsy Electroencephalography Epilepsy Humans Pilot Projects Seizures adolescent adult Article body temperature child clinical article computed tomographic angiography computer assisted tomography drug resistant epilepsy electroencephalogram eligibility criteria epileptic discharge female focused ultrasound therapy follow up Fourier transform functional neuroimaging general hospital human information processing male memory disorder MR-guided focused ultrasound neurologic examination neuromodulation neuronavigation nuclear magnetic resonance imaging outcome assessment pilot study prospective study seizure spectroscopy stereoelectroencephalography treatment planning video surveillance animal diagnostic imaging drug resistant epilepsy electroencephalography epilepsy procedures seizure
Objective: The neuromodulatory effects of focused ultrasound (FUS) have been demonstrated in animal epilepsy models; however, the safety and efficacy of FUS in humans with epilepsy have not been well established. Patients with drug-resistant epilepsy (DRE) undergoing stereo-electroencephalography (SEEG) provide an opportunity to investigate the neuromodulatory effects of FUS in humans. Methods: Patients with DRE undergoing SEEG for localization of the seizure onset zone (SOZ) were prospectively enrolled. FUS was delivered to the SOZ using a neuronavigation-guided FUS system (ceiling spatial-peak temporal-average intensity level = 2.8 W/cm2, duty cycle = 30%, modulating duration = 10 min). Simultaneous SEEG recordings were obtained during sonication and for 3 days after treatment. Seizures, interictal epileptiform discharges, and adverse events after FUS were monitored. Results: Six patients met the eligibility criteria and completed FUS treatment. A decrease in seizure frequency was observed in two patients within the 3-day follow-up; however, one patient presented an increase in the frequency of subclinical seizures. Posttreatment magnetic resonance imaging revealed neither lesion nor brain edema. Significant changes in spectral power of SEEG were noted at the targeted electrodes during FUS treatment. One patient reported subjective scalp heating during FUS, and one patient developed transient naming and memory impairment that resolved within 3 weeks after FUS. Significance: FUS can be safely delivered to the SOZ of patients with DRE, resulting in significant changes in spectral power of SEEG. A larger sample cohort and pursuing optimal sonication parameters will be required to elucidate the neuromodulatory effects of FUS when used for seizure control. © 2021 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy
url
https://doi.org/10.1111/epi.17105View
Published (Version of record) Open

Metrics

5 Record Views

Details

Logo image